Innoviva (INVA) Enterprise Value (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.46% |
| Dec 31, 2025 | -15.62% |
| Sep 30, 2025 | -19.87% |
| Jun 30, 2025 | -24.58% |
| Mar 31, 2025 | -4.63% |
| Dec 31, 2024 | -17.01% |
| Sep 30, 2024 | -20.10% |
| Jun 30, 2024 | -21.67% |
| Mar 31, 2024 | 7.83% |
| Dec 31, 2023 | -7.51% |
| Sep 30, 2023 | -4.03% |
| Jun 30, 2023 | -20.12% |
| Mar 31, 2023 | 50.51% |
| Dec 31, 2022 | 3.33% |
| Sep 30, 2022 | -6.17% |
| Jun 30, 2022 | -30.80% |
| Mar 31, 2022 | -140.00% |
| Dec 31, 2021 | -95.86% |
| Sep 30, 2021 | -322.81% |
| Jun 30, 2021 | 109.38% |
| Mar 31, 2021 | -23.58% |
| Dec 31, 2020 | 58.46% |
| Sep 30, 2020 | -12.76% |
| Jun 30, 2020 | -6.60% |
| Mar 31, 2020 | -10.99% |
| Dec 31, 2019 | -14.88% |
| Sep 30, 2019 | -22.14% |
| Jun 30, 2019 | -27.24% |
| Mar 31, 2019 | -64.91% |
| Dec 31, 2018 | -108.86% |
| Sep 30, 2018 | 50.36% |
| Jun 30, 2018 | -89.67% |
| Mar 31, 2018 | 56.84% |
| Dec 31, 2017 | 23.35% |
| Sep 30, 2017 | -24.01% |
| Jun 30, 2017 | 20.13% |
| Mar 31, 2017 | -12.88% |
| Dec 31, 2016 | -0.98% |
| Sep 30, 2016 | 3.18% |
| Jun 30, 2016 | 8.52% |
| Mar 31, 2016 | 10.19% |
| Dec 31, 2015 | 9.17% |
| Sep 30, 2015 | 10.06% |
| Jun 30, 2015 | 8.71% |
| Mar 31, 2015 | -4.42% |
| Dec 31, 2014 | 8.59% |
| Sep 30, 2014 | 21.34% |
| Jun 30, 2014 | 9.83% |
| Mar 31, 2014 | 20.25% |
| Dec 31, 2013 | 8.11% |
| Sep 30, 2013 | -14.25% |
| Jun 30, 2013 | 3.50% |
| Mar 31, 2013 | -84.74% |
| Dec 31, 2012 | 9.13% |
| Sep 30, 2012 | 7.46% |
| Jun 30, 2012 | -47.62% |
| Mar 31, 2012 | 16.92% |
| Dec 31, 2011 | 9.15% |
| Sep 30, 2011 | 6.59% |
| Jun 30, 2011 | -91.98% |
| Mar 31, 2011 | 52.24% |
| Dec 31, 2010 | -390.64% |
| Sep 30, 2010 | 9.49% |